DE59107814D1 - Impfstoff gegen drogen - Google Patents
Impfstoff gegen drogenInfo
- Publication number
- DE59107814D1 DE59107814D1 DE59107814T DE59107814T DE59107814D1 DE 59107814 D1 DE59107814 D1 DE 59107814D1 DE 59107814 T DE59107814 T DE 59107814T DE 59107814 T DE59107814 T DE 59107814T DE 59107814 D1 DE59107814 D1 DE 59107814D1
- Authority
- DE
- Germany
- Prior art keywords
- drugs
- drug
- vaccine
- vaccine against
- against drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940079593 drug Drugs 0.000 title abstract 8
- 239000003814 drug Substances 0.000 title abstract 8
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 208000030507 AIDS Diseases 0.000 abstract 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 abstract 1
- 229960003920 cocaine Drugs 0.000 abstract 1
- 229960002069 diamorphine Drugs 0.000 abstract 1
- 230000000857 drug effect Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0013—Therapeutic immunisation against small organic molecules, e.g. cocaine, nicotine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH2720/90A CH678394A5 (enExample) | 1990-08-22 | 1990-08-22 | |
| PCT/CH1991/000016 WO1992003163A1 (de) | 1990-08-22 | 1991-01-17 | Impfstoff und immunserum gegen drogen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE59107814D1 true DE59107814D1 (de) | 1996-06-20 |
Family
ID=4240096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE59107814T Expired - Lifetime DE59107814D1 (de) | 1990-08-22 | 1991-01-17 | Impfstoff gegen drogen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0496839B2 (enExample) |
| JP (1) | JPH05502871A (enExample) |
| AT (1) | ATE137977T1 (enExample) |
| AU (1) | AU7050091A (enExample) |
| CA (1) | CA2067205C (enExample) |
| CH (1) | CH678394A5 (enExample) |
| DE (1) | DE59107814D1 (enExample) |
| WO (1) | WO1992003163A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6210677B1 (en) | 1993-01-29 | 2001-04-03 | Robert C. Bohannon | Method to reduce the physiologic effects of drugs on mammals |
| ES2162139T5 (es) * | 1993-03-23 | 2008-05-16 | Smithkline Beecham Biologicals S.A. | Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado. |
| AU776410B2 (en) * | 1995-03-31 | 2004-09-09 | Xenova Research Limited | Hapten-carrier conjugates for use in drug-abuse therapy |
| US5840307A (en) * | 1995-03-31 | 1998-11-24 | Immulogic Pharmacuetical Corp. | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation |
| PT814843E (pt) * | 1995-03-31 | 2004-04-30 | Xenova Res Ltd | Conjugados de hapteno-transportador para utilizacao na terapia de abuso de drogas |
| US5876727A (en) * | 1995-03-31 | 1999-03-02 | Immulogic Pharmaceutical Corporation | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| US6063908A (en) * | 1996-07-02 | 2000-05-16 | Roche Diagnostics Corporation | Reagents for lysergic acid diethylamide immunoassay |
| KR100538388B1 (ko) * | 1996-09-30 | 2005-12-22 | 지노버 리서치 리미티드 | 약물남용 치료시에 사용되는 불완전항원-담체 포합체 및 상기 포합체의 제조방법 |
| SE9801923D0 (sv) | 1998-05-29 | 1998-05-29 | Independent Pharmaceutical Ab | Nicotine vaccine |
| US6232082B1 (en) * | 1998-12-01 | 2001-05-15 | Nabi | Hapten-carrier conjugates for treating and preventing nicotine addiction |
| WO2001081424A1 (en) * | 2000-04-20 | 2001-11-01 | The Board Of Trustees Of The University Of Arkansas | Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs |
| US7202348B2 (en) * | 2000-04-20 | 2007-04-10 | The University Of Arkansas For Medical Sciences | Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs |
| US7632929B2 (en) | 2000-04-20 | 2009-12-15 | The Board Of Trustees Of The University Of Arkansas | Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof |
| US6669937B2 (en) * | 2000-04-20 | 2003-12-30 | The Board Of Trustees Of The University Of Arkansas | Monoclonal antibody antagonists for treating medical problems associated with d-amphetamine-like drugs |
| EP1276728A2 (en) | 2000-04-24 | 2003-01-22 | ARYx Therapeutics | Ultrashort acting hypnotic barbiturates |
| EP2392345A3 (en) | 2002-07-18 | 2012-03-07 | Cytos Biotechnology AG | Hapten-carrier conjugates comprising virus like particles and uses thereof |
| MXPA04006617A (es) | 2004-07-07 | 2006-01-12 | Inst Nac De Psiquiatria Ramon | Proceso para la preparacion y uso de una vacuna bivalente contra la adiccion a la morfina-heroina. |
| WO2007147122A2 (en) | 2006-06-15 | 2007-12-21 | The Board Of Trustees Of The University Of Arkansas | Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds |
| ES2619647T3 (es) | 2007-04-20 | 2017-06-26 | Bioventures Llc | Compuestos de hapteno y composiciones y usos de los mismos |
| US9023353B2 (en) | 2013-03-13 | 2015-05-05 | The Board Of Trustees Of The University Of Arkansas | Anti-(+)—methamphetamine monoclonal antibodies |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4375414A (en) * | 1971-05-20 | 1983-03-01 | Meir Strahilevitz | Immunological methods for removing species from the blood circulatory system and devices therefor |
| US3766162A (en) * | 1971-08-24 | 1973-10-16 | Hoffmann La Roche | Barbituric acid antigens and antibodies specific therefor |
| US4045420A (en) * | 1973-05-29 | 1977-08-30 | Syva Company | Non-oxo-carbonyl containing benzoyl ecgonine and cocaine compounds polypeptide and derivatives thereof |
| US4053459A (en) * | 1975-09-24 | 1977-10-11 | Hoffmann-La Roche Inc. | Antibody specific to methaqualone and its metabolites |
| SU792869A1 (ru) * | 1979-03-30 | 1982-03-30 | Научно-Исследовательский Институт По Биологическим Испытаниям Химических Соединений | Способ получени конъюгированных антигенов барбитурова кислота-иммуногенный носитель |
| SU1123704A1 (ru) * | 1983-04-08 | 1984-11-15 | Научно-Исследовательский Институт По Биологическим Испытаниям Химических Соединений | Способ получени конъюгированных антигенов |
| DE3884731D1 (de) * | 1987-10-09 | 1993-11-11 | Ube Industries | Monoklonaler Antikörper gegen Methamphetamin, seine Herstellung, Testverfahren und Testsatz für Methamphetamin. |
| EP0363041A1 (en) * | 1988-09-21 | 1990-04-11 | Ube Industries, Ltd. | Monoclonal antibody to morphine, preparation of monoclonal antibody, assaying kit and assaying method of morphine |
-
1990
- 1990-08-22 CH CH2720/90A patent/CH678394A5/de not_active IP Right Cessation
-
1991
- 1991-01-17 JP JP3502013A patent/JPH05502871A/ja active Pending
- 1991-01-17 WO PCT/CH1991/000016 patent/WO1992003163A1/de not_active Ceased
- 1991-01-17 DE DE59107814T patent/DE59107814D1/de not_active Expired - Lifetime
- 1991-01-17 AT AT91901668T patent/ATE137977T1/de active
- 1991-01-17 CA CA002067205A patent/CA2067205C/en not_active Expired - Lifetime
- 1991-01-17 EP EP91901668A patent/EP0496839B2/de not_active Expired - Lifetime
- 1991-01-17 AU AU70500/91A patent/AU7050091A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU7050091A (en) | 1992-03-17 |
| ATE137977T1 (de) | 1996-06-15 |
| JPH05502871A (ja) | 1993-05-20 |
| CA2067205C (en) | 2009-10-27 |
| EP0496839B2 (de) | 2004-03-03 |
| CH678394A5 (enExample) | 1991-09-13 |
| CA2067205A1 (en) | 1992-02-23 |
| EP0496839B1 (de) | 1996-05-15 |
| EP0496839A1 (de) | 1992-08-05 |
| WO1992003163A1 (de) | 1992-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE137977T1 (de) | Impfstoff gegen drogen | |
| IN2008CN05409A (enExample) | ||
| CA2267456A1 (en) | Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same | |
| EP1782837A3 (en) | Hapten-carrier conjugates for use in drug-abuse therapy (nicotine) | |
| EP1003552A4 (en) | ANTIBODIES DIRECTED AGAINST LO-CD2a AND USE THEREOF TO INHIBIT THE ACTIVATION AND PROLIFERATION OF T-LYMPHOCYTES | |
| ATE254930T1 (de) | Hapten-träger-konjugate zur anwendung in der drogen-missbrauchs-therapie | |
| FR2667317B1 (fr) | Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique. | |
| FR2659323B1 (fr) | Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique. | |
| TR199900770T2 (xx) | Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�. | |
| FR2618149B1 (fr) | Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique | |
| EA199900843A1 (ru) | Синтез 1,3-оксаселеноланнуклеозидов, их активность против вируса иммунодефицита человека и против вируса гепатита-b | |
| FR2771093B1 (fr) | Derives d'imidazole, leur preparation et leur application en therapeutique | |
| FR2758329B1 (fr) | Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique | |
| FR2654106B1 (fr) | Derives phosphores de cytosine, leur preparation et leur application en therapeutique. | |
| FR2638747B1 (fr) | Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique | |
| EA199800770A1 (ru) | Лекарственный препарат для терапевтического лечения вирусного гепатита | |
| FR2668152B1 (fr) | Derives n,o spirocycliques de cyclotriphosphazenes, leur preparation et leur application en therapeutique. | |
| FR2772378B1 (fr) | Derives d'imidazole, leur preparation et leur application en therapeutique | |
| FR2666582B1 (fr) | Derives de benzimidazole, leur preparation et leur application en therapeutique. | |
| FR2735469B1 (fr) | N2-(arylsulfonyl)-l-arginylpiperidin-2-carboxylates, leur preparation et leur application en therapeutique | |
| FR2674853B1 (fr) | Derives de piperidinylguanidine, leur preparation et leur application en therapeutique. | |
| FR2646161B1 (fr) | Nouvelles lipopolyamines, leur preparation et leur emploi | |
| TNSN03066A1 (en) | Natural antibodies active against hiv virus | |
| FR2637595B1 (fr) | Derives de benzimidazole, leur preparation et leur application en therapeutique | |
| FR2672891B1 (fr) | Derives de 3-pyrazolones, leur preparation et leur application en therapeutique. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8363 | Opposition against the patent | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: CHILKA LTD., TORTOLA, BRITISH VIRGIN ISLANDS, GB |
|
| 8339 | Ceased/non-payment of the annual fee | ||
| 8370 | Indication related to discontinuation of the patent is to be deleted | ||
| 8366 | Restricted maintained after opposition proceedings |